Head of Commercial, US Oncology

About Servier Servier Pharmaceuticals is an independent, commercial-stage biopharmaceutical company built to think differently about what long-term impact can look like in healthcare. Launched in 2018 and backed by the strength and stability of the Servier Group, our foundation-governed model gives us the freedom to invest for the future, move with purpose, and stay focused on where patients need us most.

In less than a decade, we have grown from a small U.S. presence into a rapidly expanding, multi-billion-dollar organization with an award-winning culture, six commercial products, and a portfolio strengthened through bold strategic investments and innovation. Our teams are helping advance important new treatment options for patients facing serious diseases with high unmet need, particularly in rare oncology and neurology.

Our ambition is clear: to build a leading U.S. biopharmaceutical company known for scientific excellence, operational strength, and deep commitment to patients. Just as important is how we build it. We are creating a culture that values entrepreneurship, collaboration, accountability, and the belief that individuals at every level can shape the future of the company. For people who want more than a job — who want the opportunity to build, lead, grow, and make a measurable impact — Servier offers the chance to be part of a company with purpose, momentum, and the ability to help define what comes next for patients and for our industry.

Role Summary As Servier Pharmaceuticals grows and expands, it is seeking to attract a key member of its senior leadership team to be Head of Commercial, Oncology, with the mandate to provide the vision, leadership and management skills to oversee and build the commercial oncology organization. Reporting to the Chief Operating Officer, this executive will be responsible for the overall commercial success of the US oncology business.

This executive provides strategic and operational leadership across the oncology portfolio and is accountable for maximizing patient impact, revenue growth and long-term franchise value. The role will lead over a 100 marketing and sales professionals aligned to the oncology portfolio and will have general management responsibilities including oversight of all brand management, launch activities, and will hold full accountability for the delivery of the P&L of the oncology business.

This is an outstanding opportunity to serve as a driving force in building and expanding Servier’s commercial presence and success in oncology, and one that will provide broad leadership challenge, accountability and impact. The VP will partner closely with Market Access, Business Excellence, Medical and Patient Affairs, Regulatory Affairs, Manufacturing, Finance, Legal and Compliance, Corporate Affairs and Global Commercial teams to ensure seamless execution of commercial strategy across the product lifecycle.

Primary Responsibilities Strategic Leadership

• Develop and execute the U.S. oncology commercial strategy aligned with corporate growth objectives.
• Establish a multi-year strategic roadmap for marketed products and pipeline indications.
• Shape prioritization, resource allocation and investment planning for commercial opportunities across tumor types and treatment modalities.
• Translate changing market dynamics into actionable commercial strategies.

• Own full P&L accountability for the US Oncology business.
• Deliver revenue, profitability and operating income objectives as set by annual plans and budgets.
• Optimize resource allocation across brands, launches, customer segments and commercial capabilities.
• Lead the creation and finalization of annual operating plans, budgeting and mid-range plans for the oncology portfolio.

• Lead commercialization of new oncology therapies from late-stage development through launch and lifecycle management.
• Direct launch readiness planning across all commercial functions.
• Establish launch governance, milestones, governance and decision forums.
• Drive post-launch optimization through continuous market assessment and execution.

• Establish performance metrics and…